Yes Zantrene would be preferential, my idea is FTO is food for cancer and viruses. Mentioned the P2 for CS2 that there is obviously some substance that a Molecule inhibiting FTO may also impact on viruses, not just cancer. Either way if there is some correlation, it could just put FTO in the spotlight in a non-oncology space.
Ann: Breakthrough Zantrene Heart Protection Discovery, page-367
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
-0.115(7.03%) |
Mkt cap ! $259.1M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.63 | $1.52 | $167.4K | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2239 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 391 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |